Publications
200
Citations
8,141
Est. group size
~1
Recurring co-author estimate
Active years
27
Publishing since 1999
Jordi B. Torrelles studies infectious diseases, with a strong focus on tuberculosis (TB) diagnosis, drug resistance, and host immune responses, as well as respiratory viral infections such as COVID-19 and influenza. Recent work spans developing low-cost diagnostic tests for drug-resistant TB, evaluating TB and HIV in resource-limited and conflict-affected settings, and studying how viral infections and vaccines affect airway tissue and immune protection. This research combines laboratory studies (e.g., cell and organoid models) with epidemiological analyses conducted in global settings including Nigeria and the Democratic Republic of Congo.
Publication output has been variable but generally steady to increasing over the last decade, with a notable surge in 2021 and continued strong output through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
Cell Reports · 2025
- Emerging highly pathogenic H5N1 influenza triggers fibrotic remodeling in human airway organoids
Emerging Microbes & Infections · 2025
- Diagnostic accuracy of nanopore sequencing for detecting Mycobacterium tuberculosis and drug-resistant strains: a systematic review and meta-analysis
Scientific Reports · 2025
- Post COVID 19 resurgence of diphtheria in Kano, Nigeria: analysis of 18,320 cases
EBioMedicine · 2025
- <scp>HIV</scp>‐tuberculosis co‐infection in conflict zones of Nigeria
Tropical Medicine & International Health · 2025
- <i>Mycobacterium tuberculosis</i> bacillus induces pyroptosis in human lung fibroblasts
mSphere · 2025
- Risks and predictors of HIV infection among adolescents in conflict regions of Nigeria
International Journal of Adolescent Medicine and Health · 2025
- The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against <i>Mycobacterium tuberculosis</i> challenge in BCG-primed Collaborative Cross inbred mice
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Publisher Correction: Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages
Scientific Reports · 2025
- Targeting ROCK Signaling Mitigates Influenza Virus-Induced Fibrogenesis in Human Airway Organoids
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Predictors of Human Immunodeficiency Virus among Children 0–14 Years in Nigeria
International Journal of Translational Medical Research and Public Health · 2025
- Drivers of Human Immunodeficiency Virus among Pregnant Women in Conflict and Non-conflict Zones of Nigeria
International Journal of Maternal and Child Health and AIDS · 2025
- Performance of the low-cost phenotypic thin-layer agar MDR/XDR-TB Colour Test (first generation, 1G, Color Plate Test) for identifying drug-resistant Mycobacterium tuberculosis isolates in a resource-limited setting
Research Square · 2025
- A systematic landscape review of global biological sample collections from tuberculosis studies
2025
- Accuracy of the Phenotypic 1G Test to Detect Mycobacterium Tuberculosis and Drug Resistance from Sputa in the US-Mexico Border
SSRN Electronic Journal · 2025
- bioRxiv (Cold Spring Harbor Laboratory)×27
- The Journal of Immunology×11
- Frontiers in Immunology×7
- Mucosal Immunology×6
- Scientific Reports×6
- Richard Robinson
Medicine · The Ohio State University
- Tiffany A. Claeys
Medicine · The Ohio State University
- Smitha J. Sasindran
Medicine · The Ohio State University
- Oscar Rosas Mejia
Medicine · The Ohio State University
- Bridget Carruthers
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile